Total Payments
$7,250
2024 Payments
$323.44
Companies
33
Transactions
369
Medicare Patients
4,813
Medicare Billing
$560,091
Payment Breakdown by Category
Food & Beverage$7,057 (97.3%)
Education$192.86 (2.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,057 | 363 | 97.3% |
| Education | $192.86 | 6 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,062 | 53 | $0 (2023) |
| HARMONY BIOSCIENCES LLC | $665.25 | 29 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $654.20 | 37 | $0 (2024) |
| GlaxoSmithKline, LLC. | $652.47 | 40 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $574.99 | 25 | $0 (2024) |
| Baxter Healthcare | $555.76 | 23 | $0 (2023) |
| JAZZ PHARMACEUTICALS INC. | $521.48 | 25 | $0 (2024) |
| Mylan Specialty L.P. | $384.83 | 20 | $0 (2024) |
| Grifols USA, LLC | $381.24 | 23 | $0 (2023) |
| GENZYME CORPORATION | $225.16 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $323.44 | 15 | JAZZ PHARMACEUTICALS INC. ($149.81) |
| 2023 | $1,514 | 71 | Harmony Biosciences LLC ($267.81) |
| 2022 | $1,730 | 76 | Baxter Healthcare ($380.67) |
| 2021 | $1,188 | 63 | Boehringer Ingelheim Pharmaceuticals, Inc. ($210.64) |
| 2020 | $627.50 | 34 | GlaxoSmithKline, LLC. ($121.41) |
| 2019 | $628.49 | 34 | GlaxoSmithKline, LLC. ($93.92) |
| 2018 | $586.90 | 38 | GlaxoSmithKline, LLC. ($112.74) |
| 2017 | $652.10 | 38 | Genentech USA, Inc. ($152.74) |
All Payment Transactions
369 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/09/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/01/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Respiratory | ||||||
| 07/01/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $9.34 | General |
| Category: NEUROLOGY | ||||||
| 06/11/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: NEUROLOGY | ||||||
| 05/13/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $36.43 | General |
| Category: Narcoplepsy | ||||||
| 05/06/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $33.27 | General |
| Category: NEUROLOGY | ||||||
| 04/22/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $6.46 | General |
| Category: NEUROLOGY | ||||||
| 04/15/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $30.53 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/08/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: NEUROLOGY | ||||||
| 03/18/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $26.28 | General |
| Category: NEUROLOGY | ||||||
| 03/11/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $30.43 | General |
| Category: Narcoplepsy | ||||||
| 03/11/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $6.27 | General |
| Category: NEUROLOGY | ||||||
| 03/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 01/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Immunology | ||||||
| 01/22/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: NEUROLOGY | ||||||
| 12/18/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2023 | Jazz Pharmaceuticals Inc. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $29.66 | General |
| Category: NEUROLOGY | ||||||
| 12/12/2023 | Baxter Healthcare | Hillrom - Life 2000 Ventilation System (Device) | Food and Beverage | In-kind items and services | $8.13 | General |
| Category: Airway Clearance Device | ||||||
| 12/11/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Respiratory | ||||||
| 12/05/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: NEUROLOGY | ||||||
| 12/04/2023 | Baxter Healthcare | Hillrom - Life 2000 Ventilation System (Device) | Food and Beverage | In-kind items and services | $28.90 | General |
| Category: Airway Clearance Device | ||||||
| 11/21/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: IMMUNOLOGY | ||||||
| 11/02/2023 | Jazz Pharmaceuticals Inc. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $8.85 | General |
| Category: NEUROLOGY | ||||||
| 10/30/2023 | Jazz Pharmaceuticals Inc. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: NEUROLOGY | ||||||
| 10/25/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 757 | 1,035 | $317,508 | $94,052 |
| 2022 | 14 | 1,120 | 1,420 | $383,332 | $117,383 |
| 2021 | 20 | 1,475 | 2,730 | $526,638 | $165,204 |
| 2020 | 23 | 1,461 | 2,928 | $608,527 | $183,452 |
Total Patients
4,813
Total Services
8,113
Medicare Billing
$560,091
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 253 | 497 | $114,022 | $45,483 | 39.9% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 31 | 36 | $82,021 | $17,069 | 20.8% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 19 | 21 | $50,267 | $10,048 | 20.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 76 | 87 | $13,571 | $5,021 | 37.0% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 80 | 82 | $10,822 | $3,327 | 30.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 79 | 81 | $11,050 | $3,296 | 29.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $10,168 | $3,273 | 32.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 80 | 82 | $12,492 | $2,197 | 17.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 15 | $4,634 | $2,115 | 45.6% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 52 | 57 | $6,555 | $1,355 | 20.7% |
| 94762 | Test to measure oxygen level in blood using ear or finger device continuously overnight | Office | 2023 | 24 | 27 | $999.00 | $519.36 | 52.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 20 | 21 | $906.36 | $347.89 | 38.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 263 | 479 | $109,892 | $45,049 | 41.0% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 30 | 31 | $70,629 | $15,246 | 21.6% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 29 | 30 | $69,696 | $14,587 | 20.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 178 | 229 | $35,722 | $14,489 | 40.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 47 | 47 | $16,480 | $5,985 | 36.3% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 138 | 140 | $18,477 | $5,778 | 31.3% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 134 | 136 | $18,553 | $5,770 | 31.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 140 | 144 | $21,937 | $4,023 | 18.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 25 | 25 | $5,775 | $2,091 | 36.2% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 66 | 79 | $9,085 | $1,937 | 21.3% |
| 94660 | Therapy procedure using a positive pressure ventilator | Office | 2022 | 21 | 24 | $3,826 | $1,192 | 31.1% |
| 94762 | Test to measure oxygen level in blood using ear or finger device continuously overnight | Office | 2022 | 26 | 31 | $1,147 | $661.71 | 57.7% |
| 99091 | Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days | Office | 2022 | 11 | 11 | $1,508 | $313.54 | 20.8% |
About Michel Jeannot
Michel Jeannot is a Pulmonary Disease healthcare provider based in Loganville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/20/2009. The National Provider Identifier (NPI) number assigned to this provider is 1700023330.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michel Jeannot has received a total of $7,250 in payments from pharmaceutical and medical device companies, with $323.44 received in 2024. These payments were reported across 369 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($7,057).
As a Medicare-enrolled provider, Jeannot has provided services to 4,813 Medicare beneficiaries, totaling 8,113 services with total Medicare billing of $560,091. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Pulmonary Disease
- Location Loganville, GA
- Active Since 01/20/2009
- Last Updated 12/26/2012
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1700023330
Products in Payments
- DUPIXENT (Biological) $800.15
- OFEV (Drug) $595.87
- XYWAV (Drug) $472.82
- Hillrom - Life 2000 Ventilation System (Device) $448.32
- WAKIX (Drug) $334.67
- Wakix (Drug) $330.58
- ACTHAR (Biological) $277.74
- STIOLTO RESPIMAT (Drug) $247.34
- Yupelri (Drug) $231.88
- Prolastin-C Liquid (Biological) $228.74
- NUCALA (Biological) $220.69
- TRELEGY ELLIPTA (Drug) $213.83
- TEZSPIRE (Biological) $186.28
- Esbriet (Biological) $185.65
- BREZTRI (Drug) $171.75
- Prolastin-C (Biological) $152.50
- GLASSIA (Biological) $115.88
- SYMBICORT (Drug) $109.64
- ANORO (Drug) $109.53
- Life 2000 Ventilation System (Device) $103.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.